Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

Saudi Arabia · Delayed Price · Currency is SAR

214.10

-1.80 (-0.83%)

Jul 2, 2026, 3:14 PM AST

-21.05% (1Y)

Market Cap	74.94B -18.0%
Revenue (ttm)	13.98B +18.1%
Net Income	2.35B +1.1%
EPS	6.71 +1.1%
Shares Out	350.00M
PE Ratio	31.92
Forward PE	26.94
Dividend	4.83 (2.24%)
Ex-Dividend Date	May 10, 2026

Volume	100,494
Open	216.00
Previous Close	215.90
Day's Range	214.10 - 217.10
52-Week Range	210.10 - 281.20
Beta	0.05
Analysts	Buy
Price Target	270.54 (+26.36%)
Earnings Date	Jul 27, 2026

About TADAWUL:4013

Dr. Sulaiman Al Habib Medical Services Group Company, together with its subsidiaries, provides private health and support services in the Kingdom of Saudi Arabia. It operates through three segments: Hospitals/Healthcare Facilities, Pharmacies, and Other Solutions Sector. The company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities. It also provides home medical care; specialized medical laboratories; information technology and systems; facility maintenanc... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1993

Employees 10,475

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4013

Full Company Profile

Financial Performance

In 2025, TADAWUL:4013's revenue was 13.71 billion, an increase of 22.38% compared to the previous year's 11.20 billion. Earnings were 2.40 billion, an increase of 3.72%.

Financial Statements

Analyst Summary

According to 14 analysts, the average rating for 4013 stock is "Buy." The 12-month stock price target is SAR 270.54, which is an increase of 26.36% from the latest price.

Price Target

SAR 270.54

(26.36% upside)

Analyst Consensus: Buy

Stock Forecasts